Poster Session 3

Poster Session 3: Day 2 - Wed 24 Sep, 10.30 am to 11.00 am
P72Non-comparable patients in non-randomised comparative studies: misleading study design?SOHAN DESHPANDE 
P73Meta-analysis of continuous outcomes: systematic review of methods available for dealing with missing mean and standard deviation valuesIsabella Butcher 
P75Reporting of perinatal mortality and its components in Cochrane reviews: still room for improvement?Emily Bain 
P76A typology of questions for systematic reviews on complex interventionsKarin Hannes 
P77Challenges in conducting economic evaluation informed by Cochrane Reviews: case study of adherence in epilepsyCatrin Plumpton 
P78Update of the Cochrane systematic review of interventions for preventing obesity in children: a research programElizabeth Waters 
P79Challenges and considerations involved in using AMSTAR in overviews of reviewsMichelle Foisy 
P80The benefits and harms of methylphenidate treatment for attention deficit hyperactivity disorder (ADHD) in children and adolescents: preliminary resultsOle Jakob Storebø 
P82Should Cochranites adopt a specific hierarchy of outcomes?Ciprian Jauca 
P83Lack of originality in non-Cochrane systematic reviewsNicole Fusco 
P84Systematic reviews of risk factors: methodological challenges and implications for evidence reviewersHans Van Remoortel 
P85Characteristics of cross-over trials in dentistry and oral health reviewsSumanth Kumbargere Nagraj 
P86Faster may not be better: data abstraction for systematic reviewsGillian Gresham 
P87Meta-analyzing surveillance studies to estimate the burden of vaccine-preventable infectious diseaseKiran Kumar Thumburu 
P88How handling of missing data impacts trial results: a meta-epidemiological studyRobin Christensen 
P89Instant overviews, and beyond: the case for standardizing reporting in the characteristics of included studies tablesCaroline Struthers 
P90How to appraise Individual Participant Data (IPD) meta-analysis in diagnostic and prognostic risk prediction researchKarel Moons 
P91Database of appraised studies on patients’ values and preferencesPablo Alonso 
P92Malaysian authors’ perception on the degree of consensus in Cochrane Review development: a preliminary surveyNai Ming Lai 
P93Scoping review for informing and refining the question of a complex Cochrane reviewAnel Schoonees 
P95Assessing the quality of surveillance studiesNishant Jaiswal 
P96A new candidate TB vaccine: systematic review of animal studiesRufaro Kashangura 
P97Are 'Risk of bias' summary graphs in Cochrane Reviews overestimating bias? Erik VonElm 
P98Informing the methods for public health overview reviews: a descriptive analysis of Cochrane and  non-Cochrane public health overviews Philip Baker 
P99Grading the quality of evidence in existing systematic reviews: challenges and considerations Michelle Foisy 
P100A tool to measure complexity in public health interventionsRavishankar N 
P101How do systematic review users and producers interpret the stability of review findings based on GRADE quality of evidence ratings?Kylie Thaler 
P102New recommendations for the 'Implications for research' section of Cochrane reviewsGustavo Porfirio 
P103What to do if the results of conventional pairwise meta-analysis and network meta-analysis are contradictory? An example from a systematic review on the effects of antipsychotics in treatment-resistant schizophreniaStefan Leucht 
P105Update of the Cochrane systematic review of interventions for preventing obesity in children: overview of systematic reviewsElizabeth Waters 
P106Assessing adverse effects of interventions in Cochrane reviews: what types of study designs are used? Maíra Parra 
P107Cluster randomised trials: a study to help recommendations for better reporting in Cochrane reviewsMarty Richardson 
P109Handling missing data in a randomized controlled trial: example from an Attention Deficit/Hyperactive Disorder (ADHD) trialMay Loong Tan